Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Adocia (ADOCY : OTC)

• Company Description    Adocia SAS is a biotechnology company which is engaged in the development of insulin therapy. The Company develops a BioChaperone platform used for therapeutic protein delivery in regenerative medicine and chronic disease. Adocia SAS is based in Lyon, France. Number of Employees: 125

• Price / Volume Information    Yesterday's Closing Price: $11.80 Daily Weekly Monthly 20 Day Moving Average: 0 shares Shares Outstanding: 7.36 (millions) Market Capitalization: $86.84 (millions) Beta: 0.77 52 Week High: $11.80 52 Week Low: $9.80 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% 12.62% 12 Week 0.00% 9.93% Year To Date 0.00% 22.18%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 115 avenue Lacassagne - Lyon,I0 69003 FRA ph: 33-04-72-61-06-10 fax: 33-04-72-36-39-67 plaurent@newcap.fr http://www.adocia.com

• General Corporate Information    Officers Gerard Soula - Chief Executive Officer and Chairman Valerie Danaguezian - Chief Financial Officer Olivier Soula - Director Olivier Martinez - Director Dominique Takizawa - Director Peer Information Adocia (CORR.) Adocia (RSPI) Adocia (CGXP) Adocia (BGEN) Adocia (GTBP) Adocia (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 00725J102 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 7.36 Most Recent Split Date: (:1) Beta: 0.77 Market Capitalization: $86.84 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.84 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.38 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - - 09/30/21 - - Current Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - - Quick Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - - Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - - 09/30/21 - - Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©